Aviso Wealth Management Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Aviso Wealth Management bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 430 shares of the medical equipment provider’s stock, valued at approximately $211,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. M&G Plc purchased a new position in Intuitive Surgical in the 1st quarter worth about $1,318,000. TIAA Trust National Association increased its stake in Intuitive Surgical by 26.6% in the 1st quarter. TIAA Trust National Association now owns 2,729 shares of the medical equipment provider’s stock worth $1,089,000 after buying an additional 573 shares during the period. Penobscot Investment Management Company Inc. increased its stake in Intuitive Surgical by 3.2% in the 1st quarter. Penobscot Investment Management Company Inc. now owns 2,430 shares of the medical equipment provider’s stock worth $970,000 after buying an additional 75 shares during the period. O Shaughnessy Asset Management LLC increased its stake in Intuitive Surgical by 20.5% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 29,231 shares of the medical equipment provider’s stock worth $11,666,000 after buying an additional 4,973 shares during the period. Finally, UniSuper Management Pty Ltd increased its stake in Intuitive Surgical by 157.6% in the 1st quarter. UniSuper Management Pty Ltd now owns 7,250 shares of the medical equipment provider’s stock worth $2,893,000 after buying an additional 4,436 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 91,178 shares of company stock valued at $45,897,071. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Down 1.9 %

ISRG stock opened at $527.61 on Monday. The firm has a 50 day moving average of $499.29 and a 200 day moving average of $458.50. The stock has a market capitalization of $187.92 billion, a PE ratio of 84.82, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $295.02 and a 52 week high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent analyst reports. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. Mizuho raised their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Finally, Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their target price for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $524.61.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.